Healthy subjects
Conditions
Interventions
Conducting alcohol loading test after intake 2 capsules of the test-food1. More than 5 days pause period. Conducting alcohol loading test after intake 2 capsules of the test-food2. More than 5 days pa
Sponsors
CPCC Company Limited
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) Males over aged 20 when informed consent. 2) Subjects who can drink alcohol. (Include subjects who are weak against alcohol from subjective symptom and subjects who don't have liver dysfunction by doctor's judge.) 3) Subjects who have received enough description of the clinical test, understanding about the clinical test and giving written informed consent.
Exclusion criteria
Exclusion criteria: 1) Subjects who can't drink alcohol. 2) Subjects who showed strong positive reaction in patch test of alcohol. 3) Subjects who constantly use medicines suspected to have influence to the results of the clinical test. (Turmeric, shellfish, levers and other hangover supplements etc.) 4) Subjects who have previous and/or current medical history of serious disease in heart, liver, kidney, digestive organ. 5) Subjects who excessive alcohol intake. 6) Subjects who have extremely irregular dining habits, and subjects who have midnight work or irregular shift work. 7) Subjects who have previous medical history of drug and/or food allergy. 8) Subjects who are participating the other clinical tests. Subjects who participated within 4-weeks prior to the current study and/or who plan to participate the other clinical tests. 9) Subjects who donated over 200mL blood and/or blood components within the last one month to the current study. 10) Subjects who donated over 400mL blood and/or blood components within the last three month to the current study. 11) Subjects who will be collected over 1200mL blood and/or blood components, when the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. 14) Others those have been determined ineligible by principal investigator or sub-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Concentration of acetaldehyde in blood at each measurement point, AUC of blood acetaldehyde, Concentration of alcohol in blood at each measurement point, AUC of blood alcohol | — |
Secondary
| Measure | Time frame |
|---|---|
| Efficacy evaluations : VAS questionnaire, alcohol in expired gas Safety evaluation : Incidence of side effect and adverse events | — |
Countries
Japan
Contacts
Public ContactMakoto Ichinohe
CPCC Company Limited Planning & Sales Department
Outcome results
None listed